Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness.

The result showed a decreasing trend of ABCG2 and HIF‐1α in the aspirin and aspirin with cisplatin groups, which was consistent with the lightening of H460R tumor stemness, invasion and metastasis (Fig 4f ).

also in 47,180 other papers